{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T18:50:36Z","timestamp":1793213436223,"version":"4.5.0"},"reference-count":160,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Diabetes and its Complications"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.jdiacomp.2020.107834","type":"journal-article","created":{"date-parts":[[2020,12,31]],"date-time":"2020-12-31T02:28:44Z","timestamp":1609381724000},"page":"107834","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":79,"title":["Homocysteine and diabetes: Role in macrovascular and microvascular complications"],"prefix":"10.1016","volume":"35","author":[{"given":"Emir","family":"Muzurovi\u0107","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivana","family":"Kraljevi\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirsala","family":"Solak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sini\u0161a","family":"Dragni\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitri P.","family":"Mikhailidis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jdiacomp.2020.107834_bb0005","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1146\/annurev.nutr.19.1.217","article-title":"Homocysteine metabolism","volume":"19","author":"Selhub","year":"1999","journal-title":"Annu Rev Nutr."},{"key":"10.1016\/j.jdiacomp.2020.107834_bb0010","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1515\/CCLM.2005.174","article-title":"Homocysteine and vascular disease in diabetes: a double hit?","volume":"43","author":"Huijberts","year":"2005","journal-title":"Clin Chem Lab Med."},{"key":"10.1016\/j.jdiacomp.2020.107834_bb0015","doi-asserted-by":"crossref","first-page":"S141","DOI":"10.1016\/j.dsx.2016.12.023","article-title":"Implication of homocysteine in diabetes and impact of folate and vitamin B12 in diabetic population","volume":"11","author":"Mursleen","year":"2017","journal-title":"Diabetes Metab Syndr."},{"key":"10.1016\/j.jdiacomp.2020.107834_bb0020","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.atherosclerosis.2014.06.021","article-title":"Homocysteine induces the expression of C-reactive protein via NMDAr-ROS-MAPK-NF-\u03baB signal pathway in rat vascular smooth muscle cells","volume":"236","author":"Pang","year":"2014","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jdiacomp.2020.107834_bb0025","doi-asserted-by":"crossref","first-page":"462","DOI":"10.4330\/wjc.v6.i6.462","article-title":"Antioxidants, inflammation and cardiovascular disease","volume":"6","author":"Mangge","year":"2014","journal-title":"World J Cardiol."},{"key":"10.1016\/j.jdiacomp.2020.107834_bb0030","doi-asserted-by":"crossref","first-page":"5663","DOI":"10.1038\/srep05663","article-title":"Hyperhomocysteinemia is one of the risk factors associated with cerebrovascular stiffness in hypertensive patients, especially elderly males","volume":"4","author":"Okura","year":"2014","journal-title":"Sci Rep."},{"key":"10.1016\/j.jdiacomp.2020.107834_bb0035","first-page":"32","article-title":"Association between serum homocysteine and arterial stiffness in elderly: a community-based study","volume":"11","author":"Zhang","year":"2014","journal-title":"J Geriatr Cardiol."},{"key":"10.1016\/j.jdiacomp.2020.107834_bb0040","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1089\/met.2019.0011","article-title":"Homocysteine levels are associated with endothelial function in newly diagnosed type 2 diabetes mellitus patients","volume":"17","author":"Hu","year":"2019","journal-title":"Metab Syndr Relat Disord."},{"key":"10.1016\/j.jdiacomp.2020.107834_bb0045","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s13098-017-0218-0","article-title":"Type II diabetes mellitus and hyperhomocysteinemia: a complex interaction","volume":"9","author":"Platt","year":"2017","journal-title":"Diabetol Metab Syndr."},{"key":"10.1016\/j.jdiacomp.2020.107834_bb0050","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/S0026-0495(98)90031-2","article-title":"Plasma homocysteine concentrations are regulated by acute hyperinsulinemia in nondiabetic but not type 2 diabetic subjects","volume":"47","author":"Fonseca","year":"1998","journal-title":"Metabolism"},{"key":"10.1016\/j.jdiacomp.2020.107834_bb0055","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0021-9150(01)00531-7","article-title":"Homocysteine and cardiovascular disease in diabetes mellitus","volume":"159","author":"Audelin","year":"2001","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jdiacomp.2020.107834_bb0060","doi-asserted-by":"crossref","first-page":"3224","DOI":"10.2174\/1381612823666170317124913","article-title":"Homocysteine and non-cardiac vascular disease","volume":"23","author":"Katsiki","year":"2017","journal-title":"Curr Pharm Des."},{"key":"10.1016\/j.jdiacomp.2020.107834_bb0065","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1161\/01.CIR.101.13.1506","article-title":"Hyperhomocysteinemia increases risk of death, especially in type 2 diabetes","volume":"101","author":"Hoogeveen","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.jdiacomp.2020.107834_bb0070","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1056\/NEJM199804093381507","article-title":"Homocysteine and atherothrombosis","volume":"338","author":"Welch","year":"1998","journal-title":"N Engl J Med."},{"key":"10.1016\/j.jdiacomp.2020.107834_bb0075","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1177\/1076029607308390","article-title":"Homocysteine activates platelets in vitro","volume":"14","author":"Mohan","year":"2008","journal-title":"Clin Appl Thromb Hemost."},{"key":"10.1016\/j.jdiacomp.2020.107834_bb0080","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1007\/s00125-002-0888-4","article-title":"Homocysteine enhances impairment of endothelium-dependent relaxation and guanosine cyclic monophosphate formation in aortae from diabetic rabbits","volume":"45","author":"Shukla","year":"2002","journal-title":"Diabetologia"},{"key":"10.1016\/j.jdiacomp.2020.107834_bb0085","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1097\/01.mol.0000236367.42755.c1","article-title":"Small dense low-density lipoprotein and its role as an independent predictor of cardiovascular disease","volume":"17","author":"Packard","year":"2006","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.jdiacomp.2020.107834_bb0090","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1042\/BST0351175","article-title":"Homocysteine metabolism in diabetes","volume":"35","author":"Wijekoon","year":"2007","journal-title":"Biochem Soc Trans"},{"key":"10.1016\/j.jdiacomp.2020.107834_bb0095","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/s13098-019-0484-0","article-title":"Hyperhomocysteinemia is an independent risk factor of atherosclerosis in patients with metabolic syndrome","volume":"11","author":"Piazzolla","year":"2019","journal-title":"Diabetol Metab Syndr"},{"key":"10.1016\/j.jdiacomp.2020.107834_bb0100","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S0021-9150(02)00066-7","article-title":"Homocysteine and cardiovascular disease in diabetes mellitus","volume":"164","author":"Jeremy","year":"2002","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jdiacomp.2020.107834_bb0105","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.jdiacomp.2003.12.003","article-title":"Total homocysteine levels relation with chronic complications of diabetes, body composition, and other cardiovascular risk factors in a population of patients with diabetes mellitus type 2","volume":"19","author":"de Luis","year":"2005","journal-title":"J Diabetes Complications"},{"key":"10.1016\/j.jdiacomp.2020.107834_bb0110","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.2337\/diacare.24.8.1403","article-title":"Fasting plasma homocysteine levels in the insulin resistance syndrome: the Framingham Offspring Study","volume":"24","author":"Meigs","year":"2001","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jdiacomp.2020.107834_bb0115","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1093\/ajcn\/nqy234","article-title":"Effect of folate supplementation on insulin sensitivity and type 2 diabetes: a meta-analysis of randomized controlled trials","volume":"109","author":"Lind","year":"2019","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.jdiacomp.2020.107834_bb0120","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1136\/hrt.2006.093971","article-title":"Levels of homocysteine are increased in metabolic syndrome patients but are not associated with an increased cardiovascular risk, in contrast to patients without the metabolic syndrome","volume":"93","author":"Hajer","year":"2005","journal-title":"Heart"},{"key":"10.1016\/j.jdiacomp.2020.107834_bb0125","doi-asserted-by":"crossref","first-page":"328","DOI":"10.4103\/1947-2714.136913","article-title":"Cardiovascular risks in prediabetes: preliminary data on \u201cvasculopathy triad\u201d","volume":"6","author":"Nwose","year":"2014","journal-title":"N Am J Med Sci"},{"key":"10.1016\/j.jdiacomp.2020.107834_bb0130","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.clinbiochem.2015.02.015","article-title":"Inflammation, coagulation, endothelial dysfunction and oxidative stress in prediabetes-biomarkers as a possible tool for early disease detection for rural screening","volume":"48","author":"Maschirow","year":"2015","journal-title":"Clin Biochem"},{"key":"10.1016\/j.jdiacomp.2020.107834_bb0135","doi-asserted-by":"crossref","first-page":"84","DOI":"10.2337\/diacare.23.1.84","article-title":"Total homocysteine in patients with type 1 diabetes","volume":"23","author":"Pavia","year":"2000","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jdiacomp.2020.107834_bb0140","first-page":"12529","article-title":"Association of homocysteine with type 1 diabetes mellitus: a meta-analysis","volume":"8","author":"Feng","year":"2015","journal-title":"Int J Clin Exp Med"},{"key":"10.1016\/j.jdiacomp.2020.107834_bb0145","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1186\/1471-2164-14-867","article-title":"Association of homocysteine with type 2 diabetes: a meta-analysis implementing Mendelian randomization approach","volume":"14","author":"Huang","year":"2013","journal-title":"BMC Genomics"},{"key":"10.1016\/j.jdiacomp.2020.107834_bb0150","doi-asserted-by":"crossref","first-page":"533","DOI":"10.2337\/diacare.24.3.533","article-title":"Impact of insulin resistance and nephropathy on homocysteine in type 2 diabetes","volume":"24","author":"Emoto","year":"2001","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jdiacomp.2020.107834_bb0155","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.2337\/db09-0087","article-title":"Effect of homocysteine-lowering treatment with folic acid and B vitamins on risk of type 2 diabetes in women: a randomized, controlled trial","volume":"58","author":"Song","year":"2009","journal-title":"Diabetes"},{"key":"10.1016\/j.jdiacomp.2020.107834_bb0160","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3389\/fcvm.2015.00011","article-title":"No evidence of a causal relationship between plasma homocysteine and type 2 diabetes: a Mendelian Randomization Study","volume":"2","author":"Kumar","year":"2015","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.jdiacomp.2020.107834_bb0165","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.5114\/aoms.2018.79565","article-title":"Association of retinol binding protein-4, cystatin C, homocysteine and high-sensitivity C-reactive protein levels in patients with newly diagnosed type 2 diabetes mellitus","volume":"15","author":"Wang","year":"2019","journal-title":"Arch Med Sci"},{"key":"10.1016\/j.jdiacomp.2020.107834_bb0170","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1159\/000441478","article-title":"Impact of diabetes on homocysteine levels and its relationship with coronary artery disease: a single-centre cohort study","volume":"68","author":"Schaffer","year":"2016","journal-title":"Ann Nutr Metab"},{"key":"10.1016\/j.jdiacomp.2020.107834_bb0175","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.numecd.2006.03.007","article-title":"Circulating homocysteine levels in patients with type 2 diabetes mellitus","volume":"18","author":"Ndrepepa","year":"2008","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"10.1016\/j.jdiacomp.2020.107834_bb0180","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2012\/960318","article-title":"Common variants of homocysteine metabolism pathway genes and risk of type 2 diabetes and related traits in Indians","volume":"2012","author":"Chauhan","year":"2012","journal-title":"Exp Diabetes Res"},{"key":"10.1016\/j.jdiacomp.2020.107834_bb0185","doi-asserted-by":"crossref","first-page":"2750","DOI":"10.2337\/diacare.28.11.2750","article-title":"Elevated homocysteine as a risk factor for the development of diabetes in women with a previous history of gestational diabetes mellitus: a 4-year prospective study","volume":"28","author":"Cho","year":"2005","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jdiacomp.2020.107834_bb0190","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1111\/jdi.12460","article-title":"Serum homocysteine level and gestational diabetes mellitus: a meta-analysis","volume":"7","author":"Gong","year":"2016","journal-title":"J Diabetes Investig"},{"key":"10.1016\/j.jdiacomp.2020.107834_bb0195","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.2337\/diacare.23.12.1816","article-title":"Hyperhomocysteinemia in type 2 diabetes: relationship to macroangiopathy, nephropathy, and insulin resistance","volume":"23","author":"Buysschaert","year":"2000","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jdiacomp.2020.107834_bb0200","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/S1262-3636(07)70176-3","article-title":"Homocysteine concentrations and vascular complications in patients with type 2 diabetes","volume":"31","author":"Rudy","year":"2005","journal-title":"Diabetes Metab"},{"key":"10.1016\/j.jdiacomp.2020.107834_bb0205","doi-asserted-by":"crossref","first-page":"484","DOI":"10.2337\/diacare.22.3.484","article-title":"Hyperhomocysteinemia is a risk factor for coronary arteriosclerosis in Japanese patients with type 2 diabetes","volume":"22","author":"Okada","year":"1999","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jdiacomp.2020.107834_bb0210","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.jdiacomp.2003.12.002","article-title":"Homocysteine concentrations in type 2 diabetic patients with silent myocardial ischemia","volume":"18","author":"Tarkun","year":"2004","journal-title":"J Diabetes Complications"},{"key":"10.1016\/j.jdiacomp.2020.107834_bb0215","doi-asserted-by":"crossref","first-page":"94","DOI":"10.7326\/0003-4819-140-2-200401200-00009","article-title":"Elevated plasma homocysteine level is an independent predictor of coronary heart disease events in patients with type 2 diabetes mellitus","volume":"140","author":"Soinio","year":"2004","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jdiacomp.2020.107834_bb0220","doi-asserted-by":"crossref","first-page":"36","DOI":"10.3109\/07435800.2016.1171235","article-title":"Association between plasma homocysteine levels and end-organ damage in newly diagnosed type 2 diabetes mellitus patients","volume":"42","author":"Kundi","year":"2016","journal-title":"Endocr Res"},{"key":"10.1016\/j.jdiacomp.2020.107834_bb0225","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1515\/cclm-2011-0851","article-title":"Homocysteine as a determinant of left ventricular ejection fraction in patients with diabetes","volume":"50","author":"Badiou","year":"2012","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.jdiacomp.2020.107834_bb0230","doi-asserted-by":"crossref","first-page":"171","DOI":"10.3164\/jcbn.19-49","article-title":"Measurement of homocysteine: a historical perspective","volume":"65","author":"Alam","year":"2019","journal-title":"J Clin Biochem Nutr"},{"key":"10.1016\/j.jdiacomp.2020.107834_bb0235","article-title":"Interaction of smoking, hyperhomocysteinemia, and metabolic syndrome with carotid atherosclerosis: a cross-sectional study in 972 non-diabetic patients","volume":"79\u201380","author":"Azarpazhooh","year":"2020","journal-title":"Nutrition"},{"key":"10.1016\/j.jdiacomp.2020.107834_bb0240","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.atherosclerosis.2014.07.001","article-title":"Plasma total homocysteine and carotid intima-media thickness in type 1 diabetes: a prospective study","volume":"236","author":"Basu","year":"2014","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jdiacomp.2020.107834_bb0245","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1046\/j.1365-2362.2002.00936.x","article-title":"Plasma homocysteine, methylenetetrahydrofolate reductase gene polymorphism and carotid intima-media thickness in Italian type 2 diabetic patients","volume":"32","author":"Scaglione","year":"2002","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.jdiacomp.2020.107834_bb0250","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1002\/dmrr.902","article-title":"Serum homocysteine, folate, vitamin B12 levels and arterial stiffness in diabetic patients: which of them is really important in atherogenesis?","volume":"25","author":"Shargorodsky","year":"2009","journal-title":"Diabetes Metab Res Rev"},{"key":"10.1016\/j.jdiacomp.2020.107834_bb0255","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1016\/j.clinbiochem.2011.08.1136","article-title":"Role of ischemia-modified albumin and total homocysteine in estimating symptomatic lacunar infarction in type 2 diabetic patients","volume":"44","author":"Ma","year":"2011","journal-title":"Clin Biochem"},{"key":"10.1016\/j.jdiacomp.2020.107834_bb0260","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1089\/gtmb.2018.0130","article-title":"Association of PAI-1 4G\/5G polymorphism with ischemic stroke in Chinese patients with type 2 diabetes mellitus","volume":"22","author":"Li","year":"2018","journal-title":"Genet Test Mol Biomarkers"},{"key":"10.1016\/j.jdiacomp.2020.107834_bb0265","doi-asserted-by":"crossref","first-page":"589","DOI":"10.4103\/0028-3886.57808","article-title":"Polymorphism of the methylenetetrahydrofolate reductase gene association with homocysteine and ischemic stroke in type 2 diabetes","volume":"57","author":"Sun","year":"2009","journal-title":"Neurol India"},{"key":"10.1016\/j.jdiacomp.2020.107834_bb0270","first-page":"1","article-title":"Synergistic effect of the MTHFR C677T and EPHX2 G860A polymorphism on the increased risk of ischemic stroke in Chinese type 2 diabetic patients","volume":"2017","author":"Ma","year":"2017","journal-title":"J Diabetes Res"},{"key":"10.1016\/j.jdiacomp.2020.107834_bb0275","first-page":"1167","article-title":"Homocysteine, interleukin-1\u03b2, and fasting blood glucose levels as prognostic markers for diabetes mellitus complicated with cerebral infarction and correlated with carotid intima-media thickness","volume":"19","author":"Dai","year":"2020","journal-title":"Exp Ther Med"},{"key":"10.1016\/j.jdiacomp.2020.107834_bb0280","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.1468-1331.2008.02062.x","article-title":"Hyperhomocysteinaemia is a significant risk factor for white matter lesions in Japanese type 2 diabetic patients","volume":"15","author":"Shimomura","year":"2008","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.jdiacomp.2020.107834_bb0285","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1212\/01.wnl.0000280457.29680.9c","article-title":"Association of diabetes, homocysteine, and HDL with cognition and disability after stroke","volume":"69","author":"Newman","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.jdiacomp.2020.107834_bb0290","doi-asserted-by":"crossref","first-page":"4382","DOI":"10.1038\/s41598-017-04515-w","article-title":"Plasma homocysteine and cerebral small vessel disease as possible mediators between kidney and cognitive functions in patients with diabetes mellitus","volume":"7","author":"Sonoda","year":"2017","journal-title":"Sci Rep."},{"key":"10.1016\/j.jdiacomp.2020.107834_bb0295","article-title":"The association between homocysteine and ischemic stroke subtypes in Chinese","volume":"99","author":"Zhang","year":"2020","journal-title":"Medicine"},{"key":"10.1016\/j.jdiacomp.2020.107834_bb0300","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1016\/j.jstrokecerebrovasdis.2018.04.035","article-title":"Association between homocysteine and cerebral small vessel disease: a meta-analysis","volume":"27","author":"Piao","year":"2018","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"10.1016\/j.jdiacomp.2020.107834_bb0305","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1089\/ars.2007.1750","article-title":"Vascular oxidant stress and inflammation in hyperhomocysteinemia","volume":"9","author":"Papatheodorou","year":"2007","journal-title":"Antioxid Redox Signal"},{"key":"10.1016\/j.jdiacomp.2020.107834_bb0310","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1177\/1358863X14526948","article-title":"Risk factors for peripheral artery disease among patients with diabetes in Saudi Arabia","volume":"19","author":"Alzahrani","year":"2014","journal-title":"Vasc Med"},{"key":"10.1016\/j.jdiacomp.2020.107834_bb0315","first-page":"94","article-title":"Age and homocystein were risk factor for peripheral arterial disease in elderly with type 2 diabetes mellitus","volume":"42","author":"Kuswardhani","year":"2010","journal-title":"Acta Med Indones"},{"key":"10.1016\/j.jdiacomp.2020.107834_bb0320","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1007\/s00380-018-1210-9","article-title":"Age-dependent effects of homocysteine and dimethylarginines on cardiovascular mortality in claudicant patients with lower extremity arterial disease","volume":"33","author":"Jud","year":"2018","journal-title":"Heart Vessels"},{"key":"10.1016\/j.jdiacomp.2020.107834_bb0325","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/j.1523-1755.2004.00732.x","article-title":"Association between serum homocysteine and markers of impaired kidney function in adults in the United States","volume":"66","author":"Francis","year":"2004","journal-title":"Kidney Int"},{"key":"10.1016\/j.jdiacomp.2020.107834_bb0330","doi-asserted-by":"crossref","first-page":"2540","DOI":"10.1111\/j.1538-7836.2003.00500.x","article-title":"Homocysteine levels are associated with the severity of peripheral arterial disease in Type 2 diabetic patients","volume":"1","author":"Ciccarone","year":"2003","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jdiacomp.2020.107834_bb0335","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s12020-011-9544-4","article-title":"Lipoprotein(a) and homocysteine as genetic risk factors for vascular and neuropathic diabetic foot in type 2 diabetes mellitus","volume":"41","author":"Gazzaruso","year":"2011","journal-title":"Endocrine"},{"key":"10.1016\/j.jdiacomp.2020.107834_bb0340","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1002\/dmrr.1061","article-title":"Plasma homocysteine levels are associated with ulceration of the foot in patients with type 2 diabetes mellitus","volume":"26","author":"Gonz\u00e1lez","year":"2010","journal-title":"Diabetes Metab Res Rev"},{"key":"10.1016\/j.jdiacomp.2020.107834_bb0345","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.ejvs.2009.05.007","article-title":"Homocysteine and peripheral arterial disease: systematic review and meta-analysis","volume":"38","author":"Khandanpour","year":"2009","journal-title":"Eur J Vasc Endovasc Sur"},{"key":"10.1016\/j.jdiacomp.2020.107834_bb0350","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1038\/nrneph.2013.108","article-title":"Biomarkers for incident CKD: a new framework for interpreting the literature","volume":"9","author":"Shlipak","year":"2013","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.jdiacomp.2020.107834_bb0355","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1681\/ASN.2010010085","article-title":"A multi-marker approach to predict incident CKD and microalbuminuria","volume":"21","author":"Fox","year":"2010","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.jdiacomp.2020.107834_bb0360","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1159\/000444900","article-title":"Homocysteine in renal injury","volume":"2","author":"Long","year":"2016","journal-title":"Kidney Dis"},{"key":"10.1016\/j.jdiacomp.2020.107834_bb0365","doi-asserted-by":"crossref","first-page":"867","DOI":"10.3390\/ijms20040867","article-title":"The contribution of homocysteine metabolism disruption to endothelial dysfunction: state-of-the-art","volume":"20","author":"Esse","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jdiacomp.2020.107834_bb0370","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1681\/ASN.V12102181","article-title":"The kidney and homocysteine metabolism","volume":"12","author":"Friedman","year":"2001","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.jdiacomp.2020.107834_bb0375","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1046\/j.1523-1755.1999.00624.x","article-title":"Homocysteine and methionine metabolism in ESRD: a stable isotope study","volume":"56","author":"Van Guldener","year":"1999","journal-title":"Kidney Int"},{"key":"10.1016\/j.jdiacomp.2020.107834_bb0380","doi-asserted-by":"crossref","first-page":"F215","DOI":"10.1152\/ajprenal.00376.2003","article-title":"Homocysteine clearance and methylation flux rates in health and end-stage renal disease: association with S-adenosyl homocysteine","volume":"287","author":"Stam","year":"2004","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.jdiacomp.2020.107834_bb0385","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/sj.ki.5001517","article-title":"Inhibition of ceramide-redox signaling pathway blocks glomerular injury in hyperhomocysteinemic rats","volume":"70","author":"Yi","year":"2006","journal-title":"Kidney Int"},{"key":"10.1016\/j.jdiacomp.2020.107834_bb0390","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/1476-9255-6-27","article-title":"Homocysteine-induced macrophage inflammatory protein-2 production by glomerular mesangial cells is mediated by PI3 kinase and p38 MAPK","volume":"6","author":"Shastry","year":"2009","journal-title":"J Inflamm (Lond)"},{"key":"10.1016\/j.jdiacomp.2020.107834_bb0395","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1046\/j.1523-1755.1999.0550031028.x","article-title":"Plasma total homocysteine and cysteine in relation to glomerular filtration rate in diabetes mellitus","volume":"55","author":"Wollesen","year":"1999","journal-title":"Kidney Int"},{"key":"10.1016\/j.jdiacomp.2020.107834_bb0400","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0168-8227(00)00193-5","article-title":"Homocysteine and endogenous markers of renal function in type 2 diabetic patients without coronary heart disease","volume":"50","author":"Abdella","year":"2000","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.jdiacomp.2020.107834_bb0405","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1373\/clinchem.2004.044453","article-title":"Disturbed homocysteine and methionine cycle intermediates S-adenosyl homocysteine and S-adenosylmethionine are related to degree of renal insufficiency in type 2 diabetes","volume":"51","author":"Herrmann","year":"2005","journal-title":"Clin Chem"},{"key":"10.1016\/j.jdiacomp.2020.107834_bb0410","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1053\/ajkd.2001.29261","article-title":"Progression of diabetic nephropathy: role of plasma homocysteine and plasminogen activator inhibitor-1","volume":"38","author":"Hovind","year":"2001","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.jdiacomp.2020.107834_bb0415","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1007\/s11255-016-1452-3","article-title":"Hyperhomocysteinemia increases the risk of chronic kidney disease in a Chinese middle-aged and elderly population-based cohort","volume":"49","author":"Kong","year":"2016","journal-title":"Int Urol Nephrol"},{"key":"10.1016\/j.jdiacomp.2020.107834_bb0420","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/s12291-012-0192-0","article-title":"Estimated creatinine clearance, homocysteine and high sensitivity-C-reactive protein levels determination for early prediction of nephropathy and atherosclerosis risk in type 2 diabetic patients","volume":"27","author":"Deebukkhum","year":"2012","journal-title":"Indian J Clin Biochem"},{"key":"10.1016\/j.jdiacomp.2020.107834_bb0425","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1743-7075-2-13","article-title":"Age and kidney function are the primary correlates of fasting plasma total homocysteine levels in non-diabetic and diabetic adults. Results from the 1999\u20132002 National Health and Nutrition Examination Survey","volume":"2","author":"Duncan","year":"2005","journal-title":"Nutr Metab (Lond)"},{"key":"10.1016\/j.jdiacomp.2020.107834_bb0430","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/j.1365-2362.2004.01319.x","article-title":"Correlates of total homocysteine plasma concentration in type 2 diabetes","volume":"34","author":"Russo","year":"2004","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.jdiacomp.2020.107834_bb0435","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.2337\/diacare.25.11.2037","article-title":"Proteinuria as a predictor of total plasma homocysteine levels in type 2 diabetic nephropathy","volume":"25","author":"Friedman","year":"2002","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jdiacomp.2020.107834_bb0440","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/S0272-6386(99)70035-1","article-title":"End-stage renal failure in type 2 diabetes: a medical catastrophe of worldwide dimensions","volume":"34","author":"Ritz","year":"1999","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.jdiacomp.2020.107834_bb0445","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1093\/ndt\/gfl510","article-title":"The reverse epidemiology of plasma total homocysteine as a mortality risk factor is related to the impact of wasting and inflammation","volume":"22","author":"Suliman","year":"2006","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.jdiacomp.2020.107834_bb0450","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.1016\/j.transproceed.2019.02.053","article-title":"Plasma homocysteine and glutathione are independently associated with estimated glomerular filtration rates in patients with renal transplants","volume":"51","author":"Huang","year":"2019","journal-title":"Transplant Proc"},{"key":"10.1016\/j.jdiacomp.2020.107834_bb0455","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1081\/JDI-120039525","article-title":"Homocysteine in renal transplant recipients: association with transplant duration and renal function","volume":"26","author":"Sobki","year":"2004","journal-title":"Ren Fail"},{"key":"10.1016\/j.jdiacomp.2020.107834_bb0460","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.lab.2004.03.001","article-title":"Plasma homocysteine levels in living kidney donors before and after uninephrectomy","volume":"143","author":"Tsai","year":"2004","journal-title":"J Lab Clin Med"},{"key":"10.1016\/j.jdiacomp.2020.107834_bb0465","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.2337\/diacare.24.10.1805","article-title":"The relationship among homocysteine, creatinine clearance, and albuminuria in patients with type 2 diabetes","volume":"24","author":"Davies","year":"2001","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jdiacomp.2020.107834_bb0470","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.cccn.2004.05.006","article-title":"Coagulation and inflammation in overt diabetic nephropathy: association with hyperhomocysteinemia","volume":"348","author":"Aso","year":"2004","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.jdiacomp.2020.107834_bb0475","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1007\/s001250050969","article-title":"Plasma homocysteine is related to albumin excretion rate in patients with diabetes mellitus: a new link between diabetic nephropathy and cardiovascular disease?","volume":"41","author":"Chico","year":"1998","journal-title":"Diabetologia"},{"key":"10.1016\/j.jdiacomp.2020.107834_bb0480","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2013\/407452","article-title":"Diagnostic value of the combined measurement of serum Hcy, serum Cys C, and urinary microalbumin in type 2 diabetes mellitus with early complicating diabetic nephropathy","volume":"2013","author":"Wang","year":"2013","journal-title":"ISRN Endocrinol"},{"key":"10.1016\/j.jdiacomp.2020.107834_bb0485","first-page":"11174","article-title":"Association between plasma homocysteine and progression of early nephropathy in type 2 diabetic patients","volume":"8","author":"Wang","year":"2015","journal-title":"Int J Clin Exp Med"},{"key":"10.1016\/j.jdiacomp.2020.107834_bb0490","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.cca.2014.02.007","article-title":"Association between homocysteine status and the risk of nephropathy in type 2 diabetes mellitus","volume":"431","author":"Mao","year":"2014","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.jdiacomp.2020.107834_bb0495","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1161\/01.ATV.21.1.74","article-title":"Serum homocysteine levels are associated with the development of (micro)albuminuria","volume":"21","author":"Jager","year":"2001","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jdiacomp.2020.107834_bb0500","doi-asserted-by":"crossref","first-page":"200","DOI":"10.4093\/kdj.2010.34.3.200","article-title":"Homocysteine as a risk factor for development of microalbuminuria in type 2 diabetes","volume":"34","author":"Cho","year":"2010","journal-title":"Korean Diabetes J"},{"key":"10.1016\/j.jdiacomp.2020.107834_bb0505","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/S0272-6386(04)00813-3","article-title":"Hyperhomocysteinemia and the development of chronic kidney disease in a general population: the Hisayama study","volume":"44","author":"Ninomiya","year":"2004","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.jdiacomp.2020.107834_bb0510","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/j.ejim.2014.10.014","article-title":"Elevated serum homocysteine is a predictor of accelerated decline in renal function and chronic kidney disease: a historical prospective study","volume":"25","author":"Levi","year":"2014","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.jdiacomp.2020.107834_bb0515","doi-asserted-by":"crossref","first-page":"16268","DOI":"10.1038\/srep16268","article-title":"Hyperhomocysteinemia predicts renal function decline: a prospective study in hypertensive adults","volume":"5","author":"Xie","year":"2015","journal-title":"Sci Rep"},{"key":"10.1016\/j.jdiacomp.2020.107834_bb0520","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1159\/000142725","article-title":"Two cardiovascular risk factors in one? Homocysteine and its relation to glomerular filtration rate","volume":"31","author":"Kielstein","year":"2008","journal-title":"Kidney Blood Press Res"},{"key":"10.1016\/j.jdiacomp.2020.107834_bb0525","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1007\/s00125-003-1104-x","article-title":"Homocysteine as a risk factor for nephropathy and retinopathy in Type 2 diabetes","volume":"46","author":"Looker","year":"2003","journal-title":"Diabetologia"},{"key":"10.1016\/j.jdiacomp.2020.107834_bb0530","doi-asserted-by":"crossref","first-page":"2794","DOI":"10.1111\/jcmm.14187","article-title":"Genetically elevated circulating homocysteine concentrations increase the risk of diabetic kidney disease in Chinese diabetic patients","volume":"23","author":"Ma","year":"2019","journal-title":"J Cell Mol Med"},{"key":"10.1016\/j.jdiacomp.2020.107834_bb0535","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.cca.2005.10.025","article-title":"Homocysteine and other biochemical parameters in type 2 diabetes mellitus with different diabetic duration or diabetic retinopathy","volume":"366","author":"Huang","year":"2006","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.jdiacomp.2020.107834_bb0540","doi-asserted-by":"crossref","first-page":"595","DOI":"10.4093\/dmj.2011.35.6.595","article-title":"The relationship among homocysteine, bilirubin, and diabetic retinopathy","volume":"35","author":"Cho","year":"2011","journal-title":"Diabetes Metab J"},{"key":"10.1016\/j.jdiacomp.2020.107834_bb0545","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1186\/s13000-014-0167-y","article-title":"Relationship between homocysteine level and diabetic retinopathy: a systematic review and meta-analysis","volume":"9","author":"Xu","year":"2014","journal-title":"Diagn Pathol"},{"key":"10.1016\/j.jdiacomp.2020.107834_bb0550","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s13098-018-0362-1","article-title":"Association between homocysteine level and the risk of diabetic retinopathy: a systematic review and meta-analysis","volume":"10","author":"Lei","year":"2018","journal-title":"Diabetol Metab Syndr"},{"key":"10.1016\/j.jdiacomp.2020.107834_bb0555","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.jdiacomp.2004.08.002","article-title":"Levels of plasma total adrenomedullin are related with two acute phase inflammatory reactants (fibrinogen and sialic acid) but not with markers of endothelial dysfunction in Type 1 diabetes adrenomedullin and vascular risk factors in Type 1 DM","volume":"19","author":"Garc\u00eda-Unzueta","year":"2005","journal-title":"J Diabetes Complications"},{"key":"10.1016\/j.jdiacomp.2020.107834_bb0560","first-page":"297","article-title":"Plasma homocysteine and microvascular complications in type 1 diabetes","volume":"10","author":"Vaccaro","year":"2000","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"10.1016\/j.jdiacomp.2020.107834_bb0565","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0009-8981(02)00287-5","article-title":"Plasmatic homocysteine concentration and its relationship with complications associated to diabetes mellitus","volume":"326","author":"Agull\u00f3-Ortu\u00f1o","year":"2002","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.jdiacomp.2020.107834_bb0570","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s005920200033","article-title":"Associations of plasma homocysteine concentration in subjects with type 2 diabetes mellitus","volume":"39","author":"Abdella","year":"2002","journal-title":"Acta Diabetol"},{"key":"10.1016\/j.jdiacomp.2020.107834_bb0575","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1038\/sj.eye.6700702","article-title":"Hyperhomocysteinemia in patients with diabetes mellitus with and without diabetic retinopathy","volume":"18","author":"Goldstein","year":"2004","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.jdiacomp.2020.107834_bb0580","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0026747","article-title":"Status of B-vitamins and homocysteine in diabetic retinopathy: association with vitamin-B12 deficiency and hyperhomocysteinemia","volume":"6","author":"Satyanarayana","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.jdiacomp.2020.107834_bb0585","doi-asserted-by":"crossref","first-page":"50","DOI":"10.2337\/dc07-0632","article-title":"Homocysteine and diabetic retinopathy","volume":"31","author":"Brazionis","year":"2008","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jdiacomp.2020.107834_bb0590","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1177\/112067210801800210","article-title":"Association of plasma homocysteine and macular edema in type 2 diabetes mellitus","volume":"18","author":"Aydin","year":"2008","journal-title":"Eur J Ophthalmol"},{"key":"10.1016\/j.jdiacomp.2020.107834_bb0595","first-page":"3203","article-title":"Homocysteine-mediated thrombosis and angiostasis in vascular pathobiology","volume":"119","author":"Loscalzo","year":"2009","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jdiacomp.2020.107834_bb0600","doi-asserted-by":"crossref","DOI":"10.3390\/biom10081119","article-title":"Implication of hyperhomocysteinemia in blood retinal barrier (BRB) dysfunction","volume":"10","author":"Tawfik","year":"2020","journal-title":"Biomolecules"},{"key":"10.1016\/j.jdiacomp.2020.107834_bb0605","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1167\/iovs.12-10536","article-title":"Alterations of retinal vasculature in cystathionine-Beta-synthase mutant mice, a model of hyperhomocysteinemia","volume":"54","author":"Tawfik","year":"2013","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.jdiacomp.2020.107834_bb0610","doi-asserted-by":"crossref","first-page":"2573","DOI":"10.1016\/j.ajpath.2014.05.018","article-title":"Alterations of retinal vasculature in cystathionine-\u03b2-synthase heterozygous mice: a model of mild to moderate hyperhomocysteinemia","volume":"184","author":"Tawfik","year":"2014","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jdiacomp.2020.107834_bb0615","doi-asserted-by":"crossref","first-page":"5515","DOI":"10.1167\/iovs.10-6870","article-title":"The role of N-methyl-D-aspartate receptor activation in homocysteine-induced death of retinal ganglion cells","volume":"52","author":"Ganapathy","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.jdiacomp.2020.107834_bb0620","doi-asserted-by":"crossref","first-page":"11952","DOI":"10.1038\/s41598-017-09731-y","article-title":"Hyperhomocysteinemia alters retinal endothelial cells barrier function and angiogenic potential via activation of oxidative stress","volume":"7","author":"Mohamed","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.jdiacomp.2020.107834_bb0625","doi-asserted-by":"crossref","first-page":"393","DOI":"10.3390\/biom10030393","article-title":"Homocysteine induces inflammation in retina and brain","volume":"10","author":"Elsherbiny","year":"2020","journal-title":"Biomolecules"},{"key":"10.1016\/j.jdiacomp.2020.107834_bb0630","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/191497","article-title":"Homocysteine serum levels in diabetic patients with non proliferative, proliferative and without retinopathy","volume":"2014","author":"Malaguarnera","year":"2014","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.jdiacomp.2020.107834_bb0635","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/j.1529-8027.2012.00408.x","article-title":"Plasma homocysteine levels are independently associated with the severity of peripheral polyneuropathy in type 2 diabetic subjects","volume":"17","author":"Gonz\u00e1lez","year":"2012","journal-title":"J Peripher Nerv Syst"},{"key":"10.1016\/j.jdiacomp.2020.107834_bb0640","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s40618-015-0365-9","article-title":"Diabetic neuropathy is not associated with homocysteine, folate, vitamin B12 levels, and MTHFR C677T mutation in type 2 diabetic outpatients taking metformin","volume":"39","author":"Russo","year":"2016","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.jdiacomp.2020.107834_bb0645","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/S1566-0702(00)00262-9","article-title":"Increasing homocysteine levels and diabetic autonomic neuropathy","volume":"87","author":"Cohen","year":"2001","journal-title":"Auton Neurosci"},{"key":"10.1016\/j.jdiacomp.2020.107834_bb0650","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.diabres.2011.03.020","article-title":"Association of homocysteine with peripheral neuropathy in Chinese patients with type 2 diabetes","volume":"93","author":"Jianbo","year":"2011","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.jdiacomp.2020.107834_bb0655","doi-asserted-by":"crossref","first-page":"15365","DOI":"10.4238\/2015.November.30.14","article-title":"Elevated serum homocysteine level in the development of diabetic peripheral neuropathy","volume":"14","author":"Zheng","year":"2015","journal-title":"Genet Mol Res"},{"key":"10.1016\/j.jdiacomp.2020.107834_bb0660","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1055\/s-2005-872398","article-title":"Effect of drugs on homocysteine concentrations","volume":"5","author":"Dierkes","year":"2005","journal-title":"Semin Vasc Med"},{"key":"10.1016\/j.jdiacomp.2020.107834_bb0665","doi-asserted-by":"crossref","first-page":"798","DOI":"10.3390\/nu8120798","article-title":"Metformin treatment and homocysteine: a systematic review and meta-analysis of randomized controlled trials","volume":"8","author":"Zhang","year":"2016","journal-title":"Nutrients"},{"key":"10.1016\/j.jdiacomp.2020.107834_bb0670","doi-asserted-by":"crossref","first-page":"e22","DOI":"10.2337\/dc13-2278","article-title":"Metformin causing vitamin B12 deficiency: a guilty verdict without sufficient evidence","volume":"37","author":"Obeid","year":"2014","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jdiacomp.2020.107834_bb0675","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1111\/j.1463-1326.2004.00431.x","article-title":"Inverse association between plasma homocysteine, sulphonylurea exposure and physical activity: a community-based sample of type 2 diabetes patients in the Skaraborg hypertension and diabetes project","volume":"7","author":"Hellgren","year":"2005","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.jdiacomp.2020.107834_bb0680","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.clinthera.2006.05.012","volume":"28","author":"Derosa","year":"2006","journal-title":"Clin Ther"},{"key":"10.1016\/j.jdiacomp.2020.107834_bb0685","first-page":"99","article-title":"Effect of lipid-lowering and anti-hypertensive drugs on plasma homocysteine levels","volume":"3","author":"Dierkes","year":"2007","journal-title":"Vasc Health Risk Manag"},{"key":"10.1016\/j.jdiacomp.2020.107834_bb0690","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.atherosclerosis.2010.08.045","article-title":"Iatrogenic hyperhomocysteinemia in patients with metabolic syndrome: a systematic review and metaanalysis","volume":"214","author":"Ntaios","year":"2011","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jdiacomp.2020.107834_bb0695","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.diabres.2012.05.027","article-title":"Effect of folic acid supplementation on plasma total homocysteine levels and glycemic control in patients with type 2 diabetes: a systematic review and meta-analysis","volume":"98","author":"Sudchada","year":"2012","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.jdiacomp.2020.107834_bb0700","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.jdiacomp.2006.09.001","article-title":"A comparative study of the glycemic control of various antidiabetic agents and the role of homocysteine in the therapy of type 2 diabetes mellitus","volume":"22","author":"Yegnanarayan","year":"2008","journal-title":"J Diabetes Complications"},{"key":"10.1016\/j.jdiacomp.2020.107834_bb0705","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.annepidem.2018.02.001","article-title":"The effects of folate supplementation on glucose metabolism and risk of type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials","volume":"28","author":"Zhao","year":"2018","journal-title":"Ann Epidemiol"},{"key":"10.1016\/j.jdiacomp.2020.107834_bb0710","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1056\/NEJMoa060900","article-title":"Homocysteine lowering with folic acid and B vitamins in vascular disease","volume":"354","author":"Lonn","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jdiacomp.2020.107834_bb0715","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1161\/hq1201.100258","article-title":"Consumption of whole grain and legume powder reduces insulin demand, lipid peroxidation, and plasma homocysteine concentrations in patients with coronary artery disease: randomized controlled clinical trial","volume":"21","author":"Jang","year":"2001","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jdiacomp.2020.107834_bb0720","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1093\/ajcn\/80.4.849","article-title":"Effect of interaction between adherence to a Mediterranean diet and the methylenetetrahydrofolate reductase 677C\u2192T mutation on homocysteine concentrations in healthy adults: the ATTICA Study","volume":"80","author":"Dedoussis","year":"2004","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.jdiacomp.2020.107834_bb0725","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/1475-2891-10-74","article-title":"Chronologically scheduled snacking with high-protein products within the habitual diet in type-2 diabetes patients leads to a fat mass loss: a longitudinal study","volume":"10","author":"Navas-Carretero","year":"2011","journal-title":"Nutr J"},{"key":"10.1016\/j.jdiacomp.2020.107834_bb0730","doi-asserted-by":"crossref","first-page":"289","DOI":"10.3109\/09637486.2010.529072","article-title":"The effects of tomato consumption on serum glucose, apolipoprotein B, apolipoprotein A-I, homocysteine and blood pressure in type 2 diabetic patients","volume":"62","author":"Shidfar","year":"2011","journal-title":"Int J Food Sci Nutr"},{"key":"10.1016\/j.jdiacomp.2020.107834_bb0735","doi-asserted-by":"crossref","first-page":"7435","DOI":"10.1039\/C9FO01796H","article-title":"Daily consumption of fruit-flavored yoghurt enriched with vitamins B contributes to lower energy intake and body weight reduction, in type 2 diabetic patients: a randomized clinical trial","volume":"10","author":"Yanni","year":"2019","journal-title":"Food Funct"},{"key":"10.1016\/j.jdiacomp.2020.107834_bb0740","first-page":"436","article-title":"Effects of saffron on homocysteine, and antioxidant and inflammatory biomarkers levels in patients with type 2 diabetes mellitus: a randomized double-blind clinical trial","volume":"9","author":"Shahbazian","year":"2019","journal-title":"Avicenna J Phytomed"},{"key":"10.1016\/j.jdiacomp.2020.107834_bb0745","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1093\/ajcn\/72.2.324","article-title":"The controversy over homocysteine and cardiovascular risk","volume":"72","author":"Ueland","year":"2000","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.jdiacomp.2020.107834_bb0750","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S0021-9150(01)00442-7","article-title":"The effect of glucose and insulin on the activity of methylene tetrahydrofolate reductase and cystathionine-beta-synthase: studies in hepatocytes","volume":"158","author":"Dicker-Brown","year":"2001","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jdiacomp.2020.107834_bb0755","doi-asserted-by":"crossref","first-page":"2520","DOI":"10.1161\/01.CIR.98.23.2520","article-title":"Common methylenetetrahydrofolate reductase gene mutation leads to hyperhomocysteinaemia but not to vascular disease: the result of a meta-analysis","volume":"98","author":"Brattstrom","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.jdiacomp.2020.107834_bb0760","doi-asserted-by":"crossref","first-page":"2573","DOI":"10.1161\/01.CIR.96.8.2573","article-title":"Thermolabile methylenetetrahydrofolate reductase in coronary artery disease","volume":"96","author":"Kluijtmans","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.jdiacomp.2020.107834_bb0765","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1161\/01.ATV.19.5.1316","article-title":"Determinants of fasting and post-methionine homocysteine levels in families predisposed to hyperhomocysteinemia and premature vascular disease","volume":"19","author":"de Jong","year":"1999","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jdiacomp.2020.107834_bb0770","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1159\/000480447","article-title":"MTHFR A1298C and C677T polymorphisms are associated with increased risk of venous thromboembolism: a retrospective chart review study","volume":"138","author":"Liu","year":"2017","journal-title":"Acta Haematol"},{"key":"10.1016\/j.jdiacomp.2020.107834_bb0775","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/0021-9150(95)05529-6","article-title":"Post-methionine load hyperhomocysteinemia in persons with normal fasting total plasma homocysteine: initial results from the NHLBI Family Heart Study","volume":"116","author":"Bostom","year":"1995","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jdiacomp.2020.107834_bb0780","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0022-2143(98)90027-0","article-title":"Methionine loading test is necessary for detection of hyperhomocysteinemia","volume":"132","author":"van der Griend","year":"1998","journal-title":"J Lab Clin Med"},{"key":"10.1016\/j.jdiacomp.2020.107834_bb0785","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0026-0495(96)90211-5","article-title":"Hyperhomocysteinemia following a methionine load in patients with non-insulin-dependent diabetes mellitus and macrovascular disease","volume":"45","author":"Munshi","year":"1996","journal-title":"Metabolism"},{"key":"10.1016\/j.jdiacomp.2020.107834_bb0790","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1053\/meta.2002.32731","article-title":"The effect of troglitazone on plasma homocysteine, hepatic and red blood cell S-adenosyl methionine, and S-adenosyl homocysteine and enzymes in homocysteine metabolism in Zucker rats","volume":"51","author":"Fonseca","year":"2002","journal-title":"Metabolism"},{"key":"10.1016\/j.jdiacomp.2020.107834_bb0795","article-title":"Protective effect of metformin on BPA-induced liver toxicity in rats through upregulation of cystathionine \u03b2 synthase and cystathionine \u03b3 lyase expression","volume":"750","author":"Sun","year":"2020","journal-title":"Sci Total Environ."},{"key":"10.1016\/j.jdiacomp.2020.107834_bb0800","doi-asserted-by":"crossref","first-page":"344","DOI":"10.5551\/jat.25478","article-title":"High-sensitivity C-reactive protein, lipoprotein (a) and homocysteine are risk factors for coronary artery disease in Japanese patients with peripheral arterial disease","volume":"22","author":"Kumakura","year":"2015","journal-title":"J Atheroscler Thromb"}],"container-title":["Journal of Diabetes and its Complications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1056872720306358?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1056872720306358?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T00:12:55Z","timestamp":1761005575000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1056872720306358"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":160,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["S1056872720306358"],"URL":"https:\/\/doi.org\/10.1016\/j.jdiacomp.2020.107834","relation":{},"ISSN":["1056-8727"],"issn-type":[{"value":"1056-8727","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Homocysteine and diabetes: Role in macrovascular and microvascular complications","name":"articletitle","label":"Article Title"},{"value":"Journal of Diabetes and its Complications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jdiacomp.2020.107834","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"107834"}}